We’re getting the data. We don’t know what to do with it.
Hemgenix is a one-off IV therapy that can cut the number of regular trips to the hospital in half for hemophilia patients – and ultimately reduce health care costs because of fewer bleeding incidents.
The share of commercial markets that are highly concentrated increased from 71% to 75%, from 2014 to 2021.
Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!
- Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
- Exclusive discounts on BenefitsPRO.com and ALM events.
Copyright © 2022 ALM Global, LLC. All Rights Reserved.